` BIOTEC (Bio Green Energy Tech PCL) vs MAERSK B (AP Moeller - Maersk A/S) Comparison - Alpha Spread

B
BIOTEC
vs
MAERSK B

Over the past 12 months, BIOTEC has outperformed MAERSK B, delivering a return of +47% compared to the MAERSK B's +47% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BIOTEC
MAERSK B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BIOTEC Intrinsic Value
LOCKED
Unlock
MAERSK B Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
B
Bio Green Energy Tech PCL
SET:BIOTEC
0.28 THB
AP Moeller - Maersk A/S
CSE:MAERSK B
15 210 DKK
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BIOTEC, MAERSK B

BIOTEC
MAERSK B
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
Bio Green Energy Tech PCL
Revenue
AP Moeller - Maersk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BIOTEC, MAERSK B

BIOTEC
MAERSK B
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
Bio Green Energy Tech PCL
SET:BIOTEC
AP Moeller - Maersk A/S
CSE:MAERSK B
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BIOTEC
3.8%
MAERSK B
21.2%

Operating Margin

BIOTEC
0.8%
MAERSK B
5.2%

Net Margin

BIOTEC
0.7%
MAERSK B
5%

FCF Margin

BIOTEC
4.1%
MAERSK B
9.2%

ROE

BIOTEC
2.6%
MAERSK B
4.8%

ROA

BIOTEC
1.1%
MAERSK B
3.1%

ROIC

BIOTEC
1.3%
MAERSK B
3%

ROCE

BIOTEC
2.3%
MAERSK B
3.8%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BIOTEC, MAERSK B

Loading
BIOTEC
MAERSK B
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BIOTEC, MAERSK B

Performance Gap Between BIOTEC and MAERSK B
LOCKED
Unlock

Performance By Year
BIOTEC, MAERSK B

Loading
BIOTEC
MAERSK B
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BIOTEC to other stocks
601919
COSCO Shipping Holdings Co Ltd
More expensive
vs BIOTEC
KNIN
Kuehne und Nagel International...
More expensive
vs BIOTEC
HLAG
Hapag Lloyd AG
More expensive
vs BIOTEC
9101
Nippon Yusen KK
More expensive
vs BIOTEC
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett